Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

Defining boundaries: The structural limits of autonomous agentic decision-making in responsible AI governance

09/09/2026 Published by Pharma Biz

The architectural evolution of artificial intelligence toward agentic systems introduces profound shifts in organizational workflows. Beyond passive retrieval or predictive... Read more

Tags: #Human Resources

The strategic management playbook for the AI era: Converting organizational capability into economic leverage

09/09/2026 Published by Pharma Biz

1. The value divergence: Why 94% of enterprises fail to scale impact Global research tracking enterprise AI adoption reveals a... Read more

Category: Uncategorized

Tags: #Capability Development

Clinical Research Organization (CRO) Consolidation: Fortrea Acquires Worldwide Clinical Trials’ Early Phase Business in $45M Transaction – Absorbing Three Texas Facilities and 200 Inpatient Beds to Expand Global Capacity to 576 Beds

09/09/2026 Published by Pharma Biz

Key Development In early September 2026, global contract research organization Fortrea Holdings Inc. (NASDAQ: FTRE) announced a definitive asset purchase... Read more

Category: Uncategorized

Tags: #M&A

Biopharmaceutical R&D Infrastructure & Scientific Computing: Gilead Sciences Commissions 182,000-Sq-Ft Research Center at Foster City Campus – Core Milestone in $32 Billion Long-Term U.S. Innovation and Biomanufacturing Commitment

09/09/2026 Published by Pharma Biz

Key Development On September 8, 2026, research-based biopharmaceutical company Gilead Sciences Inc. (NASDAQ: GILD) marked the official opening of its... Read more

Category: Uncategorized

Tags: #Global Trends

Medical-Grade Aesthetics & Private Equity Exits: Blackstone Explores $2 Billion Sale of ZO Skin Health – Premium Physician-Dispensed Skincare In High Demand Among Strategic Healthcare and Beauty Acquirers

09/09/2026 Published by Pharma Biz

Key Development On September 8, 2026, financial market disclosures reported by Reuters confirmed that private equity alternative asset manager Blackstone... Read more

Category: Uncategorized

Tags: #M&A

Thoracic Immuno-Oncology & Strategic Pipeline Recovery: Amgen’s Imdelltra® Plus AstraZeneca’s Imfinzi® Delivers Statistically Significant Overall Survival Benefit in Pivotal Phase 3 ES-SCLC Maintenance Trial

09/09/2026 Published by Pharma Biz

Key Development On September 8, 2026, biotechnology multinational Amgen (NASDAQ: AMGN) and biopharmaceutical leader AstraZeneca (LSE/Nasdaq: AZN) announced headline outcomes... Read more

Category: Uncategorized

Tags: #Global Trends

Reproductive Endocrinology & Gestational Pharmacovigilance: Danish Prospective Study Links Maternal Acetaminophen (Tylenol) Use During Pregnancy to Reduced Ovarian and Uterine Volume and Lower Follicular Reserve in Female Infants

09/09/2026 Published by Pharma Biz

Key Development On September 9, 2026, peer-reviewed findings published in the medical journal Human Reproduction Open by clinical investigators at... Read more

Category: Uncategorized

Tags: #Global Trends

Neuromuscular Oligonucleotide Therapeutics & Platform M&A Governance: Novartis’ Lead AOC Candidate Del-Desiran Misses Primary Endpoint in Pivotal Phase 3 HARBOR Trial for Myotonic Dystrophy Type 1 – Raising Scrutiny on $12 Billion Avidity Biosciences Acquisition

09/09/2026 Published by Pharma Biz

Key Development On September 8, 2026, Swiss pharmaceutical company Novartis AG reported topline results from its pivotal global Phase 3... Read more

Category: Uncategorized

Tags: #Global Trends

Targeted Thoracic Immuno-Oncology: Amgen’s DLL3-Directed T-Cell Engager Imdelltra® (Tarlatamab) Demonstrates Landmark Overall Survival Improvement in Phase 3 DeLLphi-305 Trial – Establishing New First-Line Maintenance Paradigm in Extensive-Stage SCLC

09/09/2026 Published by Pharma Biz

Key Development On September 8, 2026, biotechnology leader Amgen (NASDAQ: AMGN) reported headline outcomes from a pre-specified interim analysis of... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 21 Page 22 Page 23 … Page 224 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members